Abstract:BACKGROUND:Circulating tumor cells (CTCs) have shown prognostic relevance in many cancer types. However, the majority of current CTC capture methods rely on positive selection techniques that require a priori knowledge about the surface protein expression of disseminated CTCs, which are known to be a dynamic population. METHODS:We developed a microfluidic CTC capture chip that incorporated a nanoroughened glass substrate for capturing CTCs from blood samples. Our CTC capture chip utilized the differential adhesion preference of cancer cells to nanoroughened etched glass surfaces as compared to normal blood cells and thus did not depend on the physical size or surface protein expression of CTCs. RESULTS:The microfluidic CTC capture chip was able to achieve a superior capture yield for both epithelial cell adhesion molecule positive (EpCAM+) and EpCAM- cancer cells in blood samples. Additionally, the microfluidic CTC chip captured CTCs undergoing transforming growth factor beta-induced epithelial-to-mesenchymal transition (TGF-β-induced EMT) with dynamically down-regulated EpCAM expression. In a mouse model of human breast cancer using EpCAM positive and negative cell lines, the number of CTCs captured correlated positively with the size of the primary tumor and was independent of their EpCAM expression. Furthermore, in a syngeneic mouse model of lung cancer using cell lines with differential metastasis capability, CTCs were captured from all mice with detectable primary tumors independent of the cell lines' metastatic ability. CONCLUSIONS:The microfluidic CTC capture chip using a novel nanoroughened glass substrate is broadly applicable to capturing heterogeneous CTC populations of clinical interest independent of their surface marker expression and metastatic propensity. We were able to capture CTCs from a non-metastatic lung cancer model, demonstrating the potential of the chip to collect the entirety of CTC populations including subgroups of distinct biological and phenotypical properties. Further exploration of the biological potential of metastatic and presumably non-metastatic CTCs captured using the microfluidic chip will yield insights into their relevant differences and their effects on tumor progression and cancer outcomes.

3d Artificial Fiber Device For Highly Efficient Capture Of Circulating Tumor Cells

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Bioinspired three-dimensional hierarchical micro/nano-structured microdevice for enhanced capture and effective release of circulating tumor cells

Capturing Circulating Tumor Cells through a Combination of Hierarchical Nanotopography and Surface Chemistry

Engineered Red Blood Cells For Capturing Circulating Tumor Cells With High Performance

Conductive Nanofibers-Enhanced Microfluidic Device for the Efficient Capture and Electrical Stimulation-Triggered Rapid Release of Circulating Tumor Cells

3D printed microfluidic devices for circulating tumor cells (CTCs) isolation

Fabrication of Channeled and Three-Dimensional Electrodes for the Integrated Capture and Detection of Invasive Circulating Tumor Cells During Hematogenous Metastasis.

A Flexible Wearable Device Coupled with Injectable Fe3O4 Nanoparticles for Capturing Circulating Tumor Cells and Triggering Their Deaths

An Implantable Magnetic Vascular Scaffold for Circulating Tumor Cell Removal in Vivo

Capture of Live Circulating Tumor Cells Via Unique Surface Charges from Cancer Patients by a Novel Nanotechnology

Fast, Reusable, Cell Uniformly Distributed Membrane Filtration Device for Separation of Circulating Tumor Cells.

Implantable Magnetic Vascular Scaffold for Circulating Tumor Cell Removal in vivo

Metabolic Glycoengineering-Programmed Nondestructive Capture of Circulating Tumor Cells.

Capture And "Self-Release" Of Circulating Tumor Cells Using Metal-Organic Framework Materials

Nanoroughened Adhesion-Based Capture of Circulating Tumor Cells with Heterogeneous Expression and Metastatic Characteristics.

Degradable Porous Nanoflower Substrate-Embedded Microfluidic Device for Capture, Release and in Situ Manipulation of Cancer Cells

Nanomaterial-based Microfluidic Chips for the Capture and Detection of Circulating Tumor Cells.

A PLGA Nanofiber Microfluidic Device for Highly Efficient Isolation and Release of Different Phenotypic Circulating Tumor Cells Based on Dual Aptamers

Highly Efficient Capture and Harvest of Circulating Tumor Cells on A Microfluidic Chip Integrated with Herringbone and Micropost Arrays

Capture of Circulating Tumor Cells by Hydrogel-Nanofiber Substrate